XML 80 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Operating expenses:    
Research and development $ 27,429 $ 12,245
In-process research and development 2,000 3,680
General and administrative 7,076 3,682
Total operating expenses 36,505 19,607
Loss from operations (36,505) (19,607)
Other income (expense)    
Interest income 114 30
Other expense (67) (55)
Change in fair value of preferred stock purchase right liability   1,615
Total other income (expense), net 47 1,590
Net loss $ (36,458) $ (18,017)
Net loss per share, basic and diluted $ (0.31) $ (0.81)
Weighted-average shares of common stock used in computing net loss per share, basic and diluted 119,491,433 22,233,422
Other comprehensive income (loss):    
Unrealized loss on marketable securities, net $ (789) $ (1)
Comprehensive loss $ (37,247) $ (18,018)